Trial intelligence / Profile preview

Effect of Fluticasone Furoate Nasal Spray on Growth in Pediatric Subjects with PAR

NCT00570492Phase 4Completed

Sponsor
GSK
Start
Nov 2007
Primary completion
Mar 2011
Modality
Orthosteric Ligands
Countries
7
01

Overview

A Phase 4 trial of fluticasone in perennial allergic rhinitis (PAR), sponsored by GSK. Started Nov 2007; status: completed.

02

Drugs

fluticasone
03

Conditions

perennial allergic rhinitis (PAR)

Beyond the preview

Go deeper on NCT00570492.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00570492.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call